Jonathan W. Lockner - Publications

Affiliations: 
2006-2011 Chemistry Scripps Research Institute, La Jolla, La Jolla, CA, United States 

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Staples MC, Herman MA, Lockner JW, Avchalumov Y, Kharidia KM, Janda KD, Roberto M, Mandyam CD. Isoxazole-9 reduces enhanced fear responses and retrieval in ethanol-dependent male rats. Journal of Neuroscience Research. PMID 34496069 DOI: 10.1002/jnr.24932  0.331
2017 Jacob NT, Anraku K, Kimishima A, Zhou B, Collins KC, Lockner JW, Ellis BA, Janda KD. A bioconjugate leveraging xenoreactive antibodies to alleviate cocaine-induced behavior. Chemical Communications (Cambridge, England). PMID 28677711 DOI: 10.1039/C7Cc04055E  0.637
2017 Galinato MH, Lockner JW, Fannon-Pavlich MJ, Sobieraj JC, Staples MC, Somkuwar SS, Ghofranian A, Chaing S, Navarro AI, Joea A, Luikart BW, Janda KD, Heyser C, Koob GF, Mandyam CD. A synthetic small-molecule Isoxazole-9 protects against methamphetamine relapse. Molecular Psychiatry. PMID 28348387 DOI: 10.1038/Mp.2017.46  0.432
2016 Jacob NT, Lockner JW, Schlosburg JE, Ellis BA, Eubanks LM, Janda KD. Investigations of Enantiopure Nicotine Haptens using an Adjuvanting Carrier in Anti-Nicotine Vaccine Development. Journal of Medicinal Chemistry. PMID 26918428 DOI: 10.1021/Acs.Jmedchem.5B01676  0.697
2015 Lockner JW, Eubanks LM, Choi JL, Lively JM, Schlosburg JE, Collins KC, Globisch D, Rosenfeld-Gunn RJ, Wilson IA, Janda KD. Flagellin as carrier and adjuvant in cocaine vaccine development. Molecular Pharmaceutics. 12: 653-62. PMID 25531528 DOI: 10.1021/Mp500520R  0.728
2015 Lockner JW, Lively JM, Collins KC, Vendruscolo JC, Azar MR, Janda KD. A conjugate vaccine using enantiopure hapten imparts superior nicotine-binding capacity. Journal of Medicinal Chemistry. 58: 1005-11. PMID 25493909 DOI: 10.1021/Jm501625J  0.546
2014 Jacob NT, Lockner JW, Kravchenko VV, Janda KD. Pharmacophore reassignment for induction of the immunosurveillance cytokine TRAIL. Angewandte Chemie (International Ed. in English). 53: 6628-31. PMID 24838721 DOI: 10.1002/Anie.201402133  0.395
2014 Collins KC, Schlosburg JE, Lockner JW, Bremer PT, Ellis BA, Janda KD. Lipid tucaresol as an adjuvant for methamphetamine vaccine development. Chemical Communications (Cambridge, England). 50: 4079-81. PMID 24615284 DOI: 10.1039/C4Cc00682H  0.697
2013 Schlosburg JE, Vendruscolo LF, Bremer PT, Lockner JW, Wade CL, Nunes AA, Stowe GN, Edwards S, Janda KD, Koob GF. Dynamic vaccine blocks relapse to compulsive intake of heroin. Proceedings of the National Academy of Sciences of the United States of America. 110: 9036-41. PMID 23650354 DOI: 10.1073/Pnas.1219159110  0.712
2013 Lockner JW, Ho SO, McCague KC, Chiang SM, Do TQ, Fujii G, Janda KD. Enhancing nicotine vaccine immunogenicity with liposomes. Bioorganic & Medicinal Chemistry Letters. 23: 975-8. PMID 23313243 DOI: 10.1016/J.Bmcl.2012.12.048  0.557
2012 Dixon DD, Lockner JW, Zhou Q, Baran PS. Scalable, divergent synthesis of meroterpenoids via "borono-sclareolide". Journal of the American Chemical Society. 134: 8432-5. PMID 22583115 DOI: 10.1021/Ja303937Y  0.652
2011 Lockner JW, Dixon DD, Risgaard R, Baran PS. Practical radical cyclizations with arylboronic acids and trifluoroborates. Organic Letters. 13: 5628-31. PMID 21923108 DOI: 10.1021/Ol2023505  0.643
Show low-probability matches.